It is a challenge to design and optimise proteins specifically for a given task. By applying artificial intelligence, Delft start-up Cradle aims to speed up this process.  

Using artificial intelligence (AI) to design and optimise proteins. This is the ambition of the start-up company Cradle. It is clear that they are responding to a real need. It is only two years since Cradle was founded, and in that short time the team has already managed to raise €33 million from investors. Its clients now include companies such as Novozymes, Twist Bioscience and Johnson & Johnson.